Moreover, reconstitution of BRCA1 in the BRCA1 mutant HCC1937 breast cancer line or BRCA1-null UWB1.289 ovarian cancer cell line resulted in a reduced sensitivity to the DNA damage chemotherapeutic agents or ionizing radiation [50], [51]. The gene discussed is BRCA1; the disease is breast carcinoma.